Search hospitals > California > Montclair
Novo Nordisk Investigational Site
Claim this profileMontclair, California 91763
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Hemostatic Disorders
Conducts research for Blood Clotting Disorders
Conducts research for Obesity
94 reported clinical trials
0 medical researchers
Summary
Novo Nordisk Investigational Site is a medical facility located in Montclair, California. This center is recognized for care of Diabetes, Type 2 Diabetes, Hemostatic Disorders, Blood Clotting Disorders, Obesity and other specialties. Novo Nordisk Investigational Site is involved with conducting 94 clinical trials across 60 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Diabetes
Global LeaderStage II
Stage I
2Type 2 Diabetes
Global LeaderStage II
Stage I
Top PIs
Clinical Trials running at Novo Nordisk Investigational Site
Chronic Kidney Disease
Obesity
Turner Syndrome
Inflammation
Non-alcoholic Fatty Liver Disease
Kidney Disease
Type 2 Diabetes
Noonan Syndrome
Syndrome
Small for Gestational Age, Turner Syndrome, Noonan Syndrome, Intrauterine Growth Restriction.
Ziltivekimab
for Cardiovascular Disease
This study is evaluating whether ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.
Recruiting1 award Phase 32 criteria
CagriSema
for Chronic Kidney Disease and Type 2 Diabetes in Obesity
This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight or obesity. CagriSema is a new investigational medicine. CagriSema cannot yet be prescribed by doctors. The study will compare CagriSema to the 2 medicines semaglutide and cagrilintide, when they are taken alone. It will also compare CagriSema to a "dummy" medicine (also called placebo) without any active ingredient. Participant will either get CagriSema 2.4 mg, semaglutide 2.4 mg, cagrilintide 2.4 mg or placebo. Which treatment participant will get is decided by chance (like flipping a coin). Study doctor will not know which of the study medicines participant will get. For each participant, the study will last for about 35 weeks.
Recruiting0 awards Phase 28 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novo Nordisk Investigational Site?
Novo Nordisk Investigational Site is a medical facility located in Montclair, California. This center is recognized for care of Diabetes, Type 2 Diabetes, Hemostatic Disorders, Blood Clotting Disorders, Obesity and other specialties. Novo Nordisk Investigational Site is involved with conducting 94 clinical trials across 60 conditions. There are 0 research doctors associated with this hospital, such as .